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this induction appears linked to NF-kB activation and oxidative
stress. Increased UCP2 levels have also been associated with
resistance to chemo- and radiotherapy in sublines of leukemia
and melanoma. Additionally, it has been shown that overexpression
of UCP2 in tumour cells reduces ROS levels and apoptosis
when treated with antitumour drugs such as doxorubicin or
camptothecin.
Two small ligands have been reported to inhibit UCP2: genipin
and chromane derivatives. Inhibition of UCP2 in tumour cells by these
compounds has been reported to cause oxidative stress and to sensitize
the cells against chemotherapeutic agents that cause oxidative stress
like arsenic trioxide, doxorubicin or menadione [2,3]. These small
molecules may, however, affect other cellular functions and increased
ROS levels may not be a direct consequence of UCP2 inhibition. We
show how detailed analysis of the effect of these compounds on the
energy metabolism and oxidative stress parameters helps to assess
their biological actions.
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Uncoupling protein 4 (UCP4) is the member of the large family
of mitochondrial anion transporters that uncouple oxidative
phoshorylation. The present study demonstrates for the ﬁrst time,
the molecular identiﬁcation of a partial Zophobas atratus UCP4 coding
sequence and the functional characterisation of ZaUCP4 in the
mitochondria of larval and pupal fat bodies of the beetle. ZaUCP4
shows a high similarity to predicted insect UCP4 isoforms and known
mammalian UCP4s, both at the nucleotide and amino acid sequence
levels. Bioenergetic studies unequivocally demonstrates UCP4 activity
in mitochondria isolated from larvae and pupae fat body. In resting,
non-phosphorylating state 4 respiration ZaUCP activity was stimu-
lated by palmitic acid and inhibited by the purine nucleotide GTP.
In phosphorylating mitochondria, ZaUCP4 activity decreased the yield
of oxidative phosphorylation. ZaUCP4 was immunodetected by using
of antibodies raised against human UCP4 as a single 36 kDa band.
Because it known that hormones inﬂuence an expression of UCPs, we
tested adipokinetic hormone (AKH), analogue of mammalian gluca-
gon, which mobilizes lipids and carbohydrates from fat body stores.
Besides this energy-mobilizing function, AKHs inhibit fat body lipid
and protein synthesis. After AKH injection, we observed the decrease in
ZaUCP4 expression at the mRNA and protein levels in both develop-
mental stages of the beetle.
Real time analysis, immunological detection and bioenergetic
characteristic indicate consistently for the higher expression of UCP4
in the Z. atratus larval fat body compared with the pupal fat body,
furthermore ZaUCP4 expression is under hormonal control. The
different expression pattern and activity of ZaUCP4 during the
larval-pupal transformation indicates an important physiological role
for UCP4 in insect fat body development and function during insect
metamorphosis. Furthermore, the regulation of UCP4 expression by
AKH indicates that it may play role in maintaining of metabolic
homeostasis in the insect.
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Experimental autoimmune encephalomyelitis (EAE), an animal
model for multiple sclerosis (MS), is characterized by inﬂammation
and demyelination of the central nervous system (CNS) and
associated with severe neurological disability, where reactive oxygen
species (ROS) and mitochondrial dysfunction play a pivotal role.
Uncoupling proteins (UCPs) belong to the mitochondrial anion
transporter family and were proposed to regulate ROS. In particular,
UCP2 has been shown to be associated with autoimmune neurode-
generative disease MS and EAE [1]. Our previous results showed that
under physiological conditions UCP4 [2; 3] and UCP2 are present in
neuronal and microglia cells of CNS respectively. Here we compare
the role of UCP2, UCP4 and UCP5 in EAE by study of protein
distribution pattern in mouse CNS using RT-PCR and Western blot.
Mice were immunized either by myelin oligodendrocyte glycoprotein
(MOG) to induce EAE or by CNS-irrelevant protein ovalbumin (OVA)
as a control. We found neuronal injury, axonal loss, reactive astro-
and microgliosis only in CNS of MOG-EAE but not in that of OVA-
immunized mice. The UCP5 was undetectable in both investigated
groups, no alteration in UCP4 abundance was observed. In contrast,
UCP2 and CD3+ up-regulation was detected in spinal cord (SC) of
OVA- and MOG-immunized mice indicating the correlation of UCP2
amount with T-lymphocyte tissue inﬁltration.
Our results provide evidence that mitochondrial UCP2 rather than
UCP4 is involved in course of EAE and support the hypothesis that the
protein up-regulation is due to unspeciﬁc T-lymphocytes activation
leading to cell proliferation and cell invasion into CNS.
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